{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T14:44:00Z","timestamp":1786373040027,"version":"build-2736575974"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and objectives<\/jats:title>\n                    <jats:p>Fibroblast growth factor 23 (FGF23) regulates phosphorus and vitamin D metabolism. Elevated FGF23 concentrations are associated with cardiovascular disease events and mortality across a broad range of kidney function, but the predictors of FGF23 concentrations in the general population are unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design, setting, participants, &amp; measurements<\/jats:title>\n                    <jats:p>We examined cross-sectional associations of dietary and nondietary parameters with plasma FGF23 in 1261 participants of the Health Professionals Follow-up Study (mean age 64 \u00b1 9, mean creatinine 0.9 \u00b1 0.2 mg\/dl, mean FGF23 64 \u00b1 28 RU\/ml).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In multivariable-adjusted analyses, each 5-year increase in age was associated with 2.1 RU\/ml higher FGF23, each 500-mg increase in phosphorus intake was associated with 3.4 RU\/ml higher FGF23, and each 0.1-mg\/dl increase in creatinine was associated with 3.4 RU\/ml higher FGF23. Participants in the highest category of body mass index had 9.5 RU\/ml higher FGF23 than those in the lowest, smokers had 17.1 RU\/ml higher FGF23 than nonsmokers, and participants with hypertension had 6.0 RU\/ml higher FGF23 than those without hypertension. With respect to biochemical parameters, higher parathyroid hormone, phosphate, uric acid, and triglyceride levels all were associated independently with higher FGF23 in models adjusted for age, creatinine, and other factors. In a subset of 748 participants with available data, some inflammatory biomarkers were associated independently with higher FGF23.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In community-dwelling adults with largely preserved kidney function, established cardiovascular risk factors and higher phosphorus intake were associated with higher FGF23. These results might explain the link between FGF23 and cardiovascular disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2215\/cjn.02740311","type":"journal-article","created":{"date-parts":[[2011,10,27]],"date-time":"2011-10-27T22:34:47Z","timestamp":1319754887000},"page":"2871-2878","source":"Crossref","is-referenced-by-count":139,"title":["Fibroblast Growth Factor 23, Cardiovascular Disease Risk Factors, and Phosphorus Intake in the Health Professionals Follow-up Study"],"prefix":"10.2215","volume":"6","author":[{"given":"Orlando M.","family":"Guti\u00e9rrez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myles","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric N.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-21-20230811","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1681\/ASN.2007010068","article-title":"How fibroblast growth factor 23 works","volume":"18","author":"Liu","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"R2-21-20230811","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMoa0706130","article-title":"Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis","volume":"359","author":"Gutierrez","year":"2008","journal-title":"N Engl J Med"},{"key":"R3-21-20230811","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1093\/ndt\/gfq309","article-title":"FGF-23 and future cardiovascular events in patients with chronic kidney disease before initiation of dialysis treatment","volume":"25","author":"Seiler","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"R4-21-20230811","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1681\/ASN.2006080936","article-title":"Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: The Mild to Moderate Kidney Disease (MMKD) Study","volume":"18","author":"Fliser","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"R5-21-20230811","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1093\/ndt\/gfp191","article-title":"High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients","volume":"24","author":"Jean","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"R6-21-20230811","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1001\/jama.2011.826","article-title":"Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease","volume":"305","author":"Isakova","year":"2011","journal-title":"JAMA"},{"key":"R7-21-20230811","doi-asserted-by":"crossref","first-page":"640","DOI":"10.7326\/0003-4819-152-10-201005180-00004","article-title":"The associations of fibroblast growth factor 23 and uncarboxylated matrix Gla protein with mortality in coronary artery disease: The Heart and Soul Study","volume":"152","author":"Parker","year":"2010","journal-title":"Ann Intern Med"},{"key":"R8-21-20230811","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1161\/CIRCULATIONAHA.108.844506","article-title":"Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease","volume":"119","author":"Gutierrez","year":"2009","journal-title":"Circulation"},{"key":"R9-21-20230811","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.2215\/CJN.02560310","article-title":"Fibroblast growth factor 23 and fetuin A are independent predictors for the coronary artery disease extent in mild chronic kidney disease","volume":"5","author":"Kanbay","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"R10-21-20230811","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/ki.2010.194","article-title":"FGF-23 and vascular dysfunction in patients with stage 3 and 4 chronic kidney disease","volume":"78","author":"Yilmaz","year":"2010","journal-title":"Kidney Int"},{"key":"R11-21-20230811","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1161\/ATVBAHA.110.214619","article-title":"Circulating fibroblast growth factor-23 is associated with fat mass and dyslipidemia in two independent cohorts of elderly individuals","volume":"31","author":"Mirza","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R12-21-20230811","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s00198-008-0780-2","article-title":"Relation between fibroblast growth factor-23, body weight and bone mineral density in elderly men","volume":"20","author":"Marsell","year":"2009","journal-title":"Osteoporos Int"},{"key":"R13-21-20230811","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.ahj.2011.02.012","article-title":"Plasma fibroblast growth factor 23, parathyroid hormone, phosphorus, and risk of coronary heart disease","volume":"161","author":"Taylor","year":"2011","journal-title":"Am Heart J"},{"key":"R14-21-20230811","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1001\/archinte.168.11.1174","article-title":"25-Hydroxyvitamin D and risk of myocardial infarction in men: A prospective study","volume":"168","author":"Giovannucci","year":"2008","journal-title":"Arch Intern Med"},{"key":"R15-21-20230811","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1093\/clinchem\/48.10.1781","article-title":"Stability of novel plasma markers associated with cardiovascular disease: Processing within 36 hours of specimen collection","volume":"48","author":"Pai","year":"2002","journal-title":"Clin Chem"},{"key":"R16-21-20230811","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1161\/01.CIR.0000079224.46084.C2","article-title":"Habitual dietary intake of n-3 and n-6 fatty acids in relation to inflammatory markers among US men and women","volume":"108","author":"Pischon","year":"2003","journal-title":"Circulation"},{"key":"R17-21-20230811","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.atherosclerosis.2007.06.022","article-title":"Inflammation, the metabolic syndrome, and risk of coronary heart disease in women and men","volume":"197","author":"Pischon","year":"2008","journal-title":"Atherosclerosis"},{"key":"R18-21-20230811","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/0002-8223(93)91754-E","article-title":"Reproducibility and validity of food intake measurements from a semiquantitative food frequency questionnaire","volume":"93","author":"Feskanich","year":"1993","journal-title":"J Am Diet Assoc"},{"key":"R19-21-20230811","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1093\/oxfordjournals.aje.a116211","article-title":"Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals","volume":"135","author":"Rimm","year":"1992","journal-title":"Am J Epidemiol"},{"key":"R20-21-20230811","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/oxfordjournals.aje.a114086","article-title":"Reproducibility and validity of a semiquantitative food frequency questionnaire","volume":"122","author":"Willett","year":"1985","journal-title":"Am J Epidemiol"},{"key":"R21-21-20230811","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/00001648-199601000-00014","article-title":"Reproducibility and validity of a self-administered physical activity questionnaire for male health professionals","volume":"7","author":"Chasan-Taber","year":"1996","journal-title":"Epidemiology"},{"key":"R22-21-20230811","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1093\/oxfordjournals.aje.a115960","article-title":"The assessment of alcohol consumption by a simple self-administered questionnaire","volume":"133","author":"Giovannucci","year":"1991","journal-title":"Am J Epidemiol"},{"key":"R23-21-20230811","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1046\/j.1525-139X.2003.16037.x","article-title":"Hidden sources of phosphorus in the typical American diet: Does it matter in nephrology?","volume":"16","author":"Uribarri","year":"2003","journal-title":"Semin Dial"},{"key":"R24-21-20230811","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1530\/EJE-07-0534","article-title":"Fibroblast growth factor-23 is associated with parathyroid hormone and renal function in a population-based cohort of elderly men","volume":"158","author":"Marsell","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"R25-21-20230811","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.atherosclerosis.2009.05.013","article-title":"Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population","volume":"207","author":"Mirza","year":"2009","journal-title":"Atherosclerosis"},{"key":"R26-21-20230811","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/MAJ.0b013e3181815498","article-title":"Fibroblast growth factor 23: A possible cause of left ventricular hypertrophy in hemodialysis patients","volume":"337","author":"Hsu","year":"2009","journal-title":"Am J Med Sci"},{"key":"R27-21-20230811","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/ki.2011.47","article-title":"Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease","volume":"79","author":"Isakova","year":"2011","journal-title":"Kidney Int"},{"key":"R28-21-20230811","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1681\/ASN.2010020221","article-title":"Low socioeconomic status associates with higher serum phosphate irrespective of race","volume":"21","author":"Gutierrez","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"R29-21-20230811","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/S0002-8223(21)07957-8","article-title":"Accuracy of methods estimating calcium and phosphorus intake in daily diets","volume":"88","author":"Oenning","year":"1988","journal-title":"J Am Diet Assoc"},{"key":"R30-21-20230811","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1359\/jbmr.090406","article-title":"Effects of hPTH(1\u201334) infusion on circulating serum phosphate, 1,25-dihydroxyvitamin D, and FGF23 levels in healthy men","volume":"24","author":"Burnett-Bowie","year":"2009","journal-title":"J Bone Miner Res"},{"key":"R31-21-20230811","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1210\/jc.2009-1909","article-title":"The calcemic response to continuous parathyroid hormone (PTH)(1\u201334) infusion in end-stage kidney disease varies according to bone turnover: A potential role for PTH(7\u201384)","volume":"95","author":"Wesseling-Perry","year":"2010","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-201112000-00021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:41:26Z","timestamp":1786369286000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-201112000-00021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":31,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.02740311","relation":{},"ISSN":["1555-9041"],"issn-type":[{"value":"1555-9041","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}